Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
初步证据表明,与既往用于治疗免疫功能低下患者的COVID-19单克隆抗体相比,Tixagevimab/Cilgavimab早期治疗具有良好的安全性和疗效。
期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines11061540
Lombardi, Andrea; Viero, Giulia; Villa, Simone; Biscarini, Simona; Palomba, Emanuele; Azzarà, Cecilia; Iannotti, Nathalie; Mariani, Bianca; Genovese, Camilla; Tomasello, Mara; Tonizzo, Anna; Fava, Marco; Valzano, Antonia Grazia; Morlacchi, Letizia Corinna; Donato, Maria Francesca; Castellano, Giuseppe; Cassin, Ramona; Carrabba, Maria; Muscatello, Antonio; Gori, Andrea; Bandera, Alessandra